抗病毒药物药理学
Pharmacology of Antiviral Drugs.
作者信息
Martin David E
机构信息
TrippBio, Inc., Jacksonville, FL 32256, USA.
出版信息
Viruses. 2025 Mar 24;17(4):459. doi: 10.3390/v17040459.
Abstract
Antiviral drug therapy has significantly evolved over the past four decades, partly driven by improved understanding of viral replication mechanisms but also advances in pharmacology and formulation technologies [...].
摘要
在过去的四十年里，抗病毒药物治疗有了显著的发展，部分原因是对病毒复制机制的理解有所提高，同时药理学和制剂技术也取得了进步[……]。
相似文献
1
Pharmacology of Antiviral Drugs.抗病毒药物药理学
Viruses. 2025 Mar 24;17(4):459. doi: 10.3390/v17040459.
2
Structural Virology: The Key Determinants in Development of Antiviral Therapeutics.结构病毒学：抗病毒治疗药物研发中的关键决定因素
Viruses. 2025 Mar 14;17(3):417. doi: 10.3390/v17030417.
3
The multifaceted roles of nucleolin in viral entry, replication, and antiviral therapy.核仁素在病毒进入、复制及抗病毒治疗中的多方面作用
Mol Biol Rep. 2025 Jun 30;52(1):655. doi: 10.1007/s11033-025-10758-y.
4
Targeting Key Stages of the Viral Entry and Life Cycle: A Comprehensive Overview of the Mechanisms of Antiviral Actions.靶向病毒进入和生命周期的关键阶段：抗病毒作用机制的全面概述
Methods Mol Biol. 2025;2927:259-286. doi: 10.1007/978-1-0716-4546-8_15.
5
Viral dynamics and anti-viral pharmacodynamics: rethinking in vitro measures of drug potency.病毒动力学与抗病毒药效学：重新思考药物效力的体外测定方法。
Trends Pharmacol Sci. 2001 Feb;22(2):97-100. doi: 10.1016/s0165-6147(00)01615-1.
6
Editorial overview: antivirals and resistance: advances and challenges ahead.社论综述：抗病毒药物与耐药性：未来的进展与挑战
Curr Opin Virol. 2014 Oct;8:iv-vii. doi: 10.1016/j.coviro.2014.08.002. Epub 2014 Aug 22.
7
Inhibitors of virus replication: recent developments and prospects.病毒复制抑制剂：最新进展与前景
Appl Microbiol Biotechnol. 2005 Mar;66(6):612-21. doi: 10.1007/s00253-004-1783-3. Epub 2004 Dec 9.
8
[Peptides--a new strategy for combating viral infections].[肽——对抗病毒感染的新策略]
Przegl Epidemiol. 2011;65(3):477-82.
9
[Mechanisms of the formation of viral resistance to chemotherapeutic preparations].[病毒对化疗制剂产生抗性的形成机制]
Vopr Virusol. 1985 May-Jun;30(3):266-79.
10
Drugs against viruses: the search continued.抗病毒药物：探索仍在继续。
Lancet. 1969 Mar 15;1(7594):559-60.
本文引用的文献
1
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis.用于慢性病毒性肝炎的超长效（XLA）抗病毒药物。
Int J Infect Dis. 2022 Jan;114:45-50. doi: 10.1016/j.ijid.2021.10.052. Epub 2021 Oct 30.
2
Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine.开发长效直接作用抗病毒系统治疗猪丙型肝炎病毒。
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):11987-11994. doi: 10.1073/pnas.2004746117. Epub 2020 May 18.
3
Long-acting injectable antiretrovirals for HIV treatment and prevention.长效注射型抗逆转录病毒药物治疗和预防艾滋病。
Curr Opin HIV AIDS. 2013 Nov;8(6):565-71. doi: 10.1097/COH.0000000000000002.
4
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.抗逆转录病毒疗法的发展及其对 HIV-1/AIDS 大流行的影响。
Antiviral Res. 2010 Jan;85(1):1-18. doi: 10.1016/j.antiviral.2009.10.002. Epub 2009 Dec 16.
5
Atriplatrade mark - HIV therapy in one pill.阿特利普拉达马克 - 一粒药治疗艾滋病。
Ther Clin Risk Manag. 2008 Jun;4(3):573-7.
Zotero 插件